One Lambda at a Glance
One Lambda develops and distributes several lines of histocompatibility (HLA) typing tests utilizing both serological and molecular technologies. One Lambda also manufactures a comprehensive line of antibody detection products, laboratory instrumentation, and computer software that are used to simplify and automate testing procedures and final test evaluations.
Incorporated January 27, 1984
Received first product order April 1, 1984
Based in Canoga Park, California, USA
260 employees servicing more than 1,400 laboratories worldwide
A Brief History
In the early days of histocompatibility, the United States government offered grants that provided research laboratories with typing reagents for HLA studies. UCLA professor Paul Terasaki utilized this funding to develop a tissue typing tray that consistently and accurately assigned HLA antigens. Terasaki trays quickly became an important tool in the HLA laboratory, and UCLA began making them available through the government grants. The distribution of this standardized tissue typing tray helped advance the early identification of HLA antigens and ensured that the relationship between HLA and transplantation would be further examined.
Research continued to reveal additional information, but advancement was challenged when the government stopped funding HLA studies in 1972. Rather than discontinue efforts, laboratories agreed to purchase the trays directly from UCLA, the only supplier of tissue typing trays in the world.
One Lambda Mission Statement One Lambda, Inc., is committed to improving the quality of life of transplant patients and their families. Therefore, One Lambda is committed to develop and produce innovative quality HLA products for the clinical and research segments of the transplant community.
To that end One Lambda strives to provide the highest level of customer service and satisfaction.
One Lambda encourages and values the contributions of its workforce by creating and maintaining a highly dynamic, creative, and safe work environment.